Abstract
Endometrial cancer is a prominent cancer which affects a considerable number of women globally. The cancer has proven to be challenging to diagnose in its early manifestations as it tends to produce symptoms which are not distinct and can be confused with other diseases. Transvaginal imaging methods are commonly adopted for an invasive visualization of the endometrium in order to arrive at a diagnosis, but this method requires expertise and access to instrumentation which is expensive and inaccessible, particularly for developing countries. This work explores the use of blood spectroscopy as a cheap and high-throughput means towards the diagnosis of endometrial cancer (type 1, type 2, mixed and atypical hyperplasia), potentially allowing for fertility-sparing treatment due to the high turnaround associated with the method.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
